山东大学耳鼻喉眼学报

• 论文 • 上一篇    下一篇

盐酸氮卓斯汀和丙酸氟替卡松治疗变应性鼻炎

冯慧伟,范献良,王哲,张辉,剪京芬   

  1. 山东大学第二医院耳鼻咽喉科, 山东 济南 250033
  • 收稿日期:2006-04-21 修回日期:1900-01-01 出版日期:2006-06-24 发布日期:2006-06-24
  • 通讯作者: 范献良

Huiwei, FAN Xian-liang, WANG Zhe, ZHANG Hui, JIAN Jing-fen   

  1. Department of Otorhinolaryngology, Second Hospital of Shandong University, Jinan 250033, Shandong, China
  • Received:2006-04-21 Revised:1900-01-01 Online:2006-06-24 Published:2006-06-24
  • Contact: FAN Xian-liang

摘要: 目的:观察鼻用盐酸氮卓斯汀和丙酸氟替卡松单独应用及联合应用治疗变应性鼻炎的疗效。方法:采用随机对照的试验方法选择109例持续性变应性鼻炎患者(15~76岁,平均35.6岁),按照2004年兰州标准分为轻度和中、重度。轻度患者随机分为2组,分别予以盐酸氮卓斯汀和丙酸氟替卡松喷鼻,均为每鼻孔1掀,2次/d,疗程30?d。中、重度患者随机分为3组,分别予以盐酸氮卓斯汀、丙酸氟替卡松(用法同上)和两药并用(两药间隔时间30?min)。结果:轻度组盐酸氮卓斯汀和丙酸氟替卡松有效率分别为86.36%和92.00%,两组有效率差异无统计学意义(P>0.05)。中、重度组单用盐酸氮卓斯汀(1组)、丙酸氟替卡松(2组)和两药并用(3组)的有效率分别为66.67%、73.33% 和96.88%,1、2组有效率差异无统计学意义(P>0.05),1、3组和2、3组差异均有统计学意义(P<0.05)。盐酸氮卓斯汀组和丙酸氟替卡松组的总有效率分别为83.78%和90.00%,两组差异无统计学意义(P>0.05)。结论:盐酸氮卓斯汀和丙酸氟替卡松可作为治疗变应性鼻炎的一线用药,二者联合可治疗中、重度变应性鼻炎。

关键词: 鼻炎, 变应性, 盐酸氮卓斯汀, 丙酸氟替卡松, 治疗结果

Abstract: Objective: To observe the effect of azelastine hydrochloride and fluticasone propionate nasal spray in treatment of allergic rhinitis. Methods: One hundred and nine patients (mean 35.6 yearslod, ranged from 15 to 76 yearslod) with persistent allergic rhinitis were randomized into mild, moderate or severe groups according to the ARIA. Patients of mild group received azelastine hydrochloride or fluticasone propionate one spray per nostril, two times per day for 30 days. Patients of moderate or severe group received azelastine hydrochloride or fluticasone propionate (with a 30minute interval), or their combination. Results: The effect in mild group was not significantly different between azelastine hydrochloride and fluticasone propionate(86.36% vs 92.00%, P>0.05). In moderate or severe groups, the response rate was 66.67%, 73.33% and 96.88% in azelastine hydrochloride (the first group), fluticasone propionate alone(the second group) and their combination (the third group). There was no significant difference between the first and the second groups(P>0.05). The response rate of the third group was significantly higher than that of the first and the second groups(both P<0.05). There was no significant difference between the total response rate of azelastine hydrochloride and of fluticasone propionate (83.78% vs 90.00%, P>0.05). Conclusion: Azelastine hydrochloride and fluticasone propionate can be used for the firstline pharmacological treatment of allergic rhinitis, and their combination can be used to treat moderate or

Key words:

[1] 吕倩,唐源,顾子君,施赛磊,刘萍,万文锦. 变应性鼻炎患者疾病获益感现状及影响因素分析[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 21-28.
[2] 顾敏,陆美萍. 纳米药物输送系统在变应性鼻炎过敏原免疫治疗中的应用进展[J]. 山东大学耳鼻喉眼学报, 2026, 40(1): 106-111.
[3] 秦娜娜,李玉芬,孙雨浩,魏健,李钦. 基于TGF-β1/Smad信号通路探讨白细胞介素13受体α2对变应性鼻炎大鼠鼻黏膜组织重塑的影响[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 71-77.
[4] 杜康丽,郑振宇,徐战将,张宇,陈露,卢梦垚. 鼻中隔偏曲并发慢性鼻窦炎风险预测模型的构建与验证[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 78-86.
[5] 熊琴, 张砚, 乌日娜, 李锋, 唐力行. 鼻用糖皮质激素在儿童中的应用[J]. 山东大学耳鼻喉眼学报, 2025, 39(6): 160-167.
[6] 许雪萌,樊磊,喻望博,蒋芝月,潘晨,黄泳芹. 奥马珠单抗联合特异性免疫治疗变应性鼻炎疗效的Meta分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 26-33.
[7] 黄焕,华红利,邓玉琴,江承洋,王雨薇,杨星海. 儿童过敏性鼻炎、扁桃体腺样体肥大和鼻窦炎之间相关性及其对临床指导价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 34-41.
[8] 刘怡君,谷悦,官大宇,杨玉成,沈暘. 翼管神经切断术在难治性变应性鼻炎中远期临床疗效和安全性[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 42-48.
[9] 张婷,王美兰,高映勤. 白细胞介素35在变应性鼻炎中的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(5): 139-147.
[10] 张竹萍,彭孜灿,肖振龙,李程,喻迪,王兴龙,陈伟,郭蓓. 新型鼻分泌物嗜酸粒细胞阳离子蛋白-髓过氧化物酶试纸在变应性鼻炎中的应用价值[J]. 山东大学耳鼻喉眼学报, 2025, 39(3): 129-134.
[11] 刘畅,杨景朴,高雨,王文佳. 长春地区儿童变应性鼻炎变应原检测结果分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 51-58.
[12] 杨娟娟,郎永耀,周文成. 孕妇分娩前后鼻眼部症状变化规律分析[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 59-64.
[13] 周荷青,申琪. 中医药治疗变应性鼻炎疗效的生物标志物研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(2): 168-176.
[14] 王曼娴,郑泉,杨亮. 细菌裂解物治疗变应性鼻炎的研究进展[J]. 山东大学耳鼻喉眼学报, 2025, 39(1): 141-145.
[15] 刘畅,方宏艳,刘敩,富东娜,王贺,王晶,杨景朴. 长春地区秋季变应性鼻炎蒿属花粉致敏特征分析[J]. 山东大学耳鼻喉眼学报, 2024, 38(5): 13-19.
Viewed
Full text


Abstract

Cited

  Shared   
  Discussed   
No Suggested Reading articles found!